NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/03/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization144.44 mln
Float10.91 mln
Earnings Date08/19/2026
1-Year Forecast
14.50
Transformational upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-57.88
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aardvark Therapeutics is a San Diego-based drug development company founded in 2017. It works on creating oral medicines that trigger the body's natural processes to help treat conditions like obesity and diabetes.
